$16.70
3.78%
Nasdaq, Dec 26, 10:00 pm CET
ISIN
US81684M1045
Symbol
SMLR

Semler Scientific Stock price

$16.70
-3.99 19.27% 1M
-22.10 56.96% 6M
-37.31 69.08% YTD
-53.27 76.14% 1Y
-14.91 47.17% 3Y
-75.31 81.85% 5Y
+14.03 525.66% 10Y
+9.71 138.84% 20Y
Nasdaq, Closing price Fri, Dec 26 2025
-0.66 3.78%
ISIN
US81684M1045
Symbol
SMLR

Key metrics

Basic
Market capitalization
$255.2m
Enterprise Value
$361.2m
Net debt
$106.0m
Cash
$10.5m
Shares outstanding
15.1m
Valuation (TTM | estimate)
P/E
5.7 | 68.2
P/S
6.9 | 7.9
EV/Sales
9.8 | 11.2
EV/FCF
negative
P/B
0.6
Financial Health
Equity Ratio
96.2%
Return on Equity
17.7%
ROCE
-0.9%
ROIC
-0.7%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$37.0m | $32.4m
EBITDA
$-4.8m | $-46.8m
EBIT
$-5.2m | $-38.3m
Net Income
$48.3m | $3.7m
Free Cash Flow
$-27.2m
Growth (TTM | estimate)
Revenue
-37.3% | -42.5%
EBITDA
-123.8% | -317.6%
EBIT
-126.7% | -282.8%
Net Income
203.8% | -90.9%
Free Cash Flow
-225.8%
Margin (TTM | estimate)
Gross
90.8%
EBITDA
-13.0% | -144.5%
EBIT
-14.1%
Net
130.8% | 11.4%
Free Cash Flow
-73.5%
More
EPS
$2.9
FCF per Share
$-1.8
Short interest
15.6%
Employees
79
Rev per Employee
$710.0k
Show more

Is Semler Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Semler Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Semler Scientific forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Semler Scientific forecast:

Buy
89%
Hold
11%

Financial data from Semler Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
37 37
37% 37%
100%
- Direct Costs 3.39 3.39
52% 52%
9%
34 34
35% 35%
91%
- Selling and Administrative Expenses 34 34
26% 26%
92%
- Research and Development Expense 4.69 4.69
6% 6%
13%
-4.81 -4.81
124% 124%
-13%
- Depreciation and Amortization 0.42 0.42
34% 34%
1%
EBIT (Operating Income) EBIT -5.23 -5.23
127% 127%
-14%
Net Profit 48 48
204% 204%
131%

In millions USD.

Don't miss a Thing! We will send you all news about Semler Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Semler Scientific Stock News

Neutral
PRNewsWire
16 days ago
NEW YORK and NEW ORLEANS , Dec. 12, 2025 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Neutral
GlobeNewsWire
19 days ago
MONSEY, N.Y., Dec. 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed merger of Semler Scientific, Inc. (Nasdaq: SMLR) (“Semler”) with Strive Asset Management (“Strive”) in an all-stock transaction under which Semler stockholders will receive 21.05 shares of Strive Class A Common Stock for each share of Semler common stock that they ow...
Neutral
PRNewsWire
2 months ago
CAMPBELL, Calif. , Oct. 28, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, Inc., the company will not be hosting a conference call or providing an accompanying...
More Semler Scientific News

Company Profile

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.

Head office United States
CEO Douglas Murphy-Chutorian
Employees 79
Founded 2007
Website www.semlerscientific.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today